Cart
sales@molnova.com
Acedoben
CAS No. 556-08-1
Acedoben( —— )
Catalog No. M15022 CAS No. 556-08-1
Acedoben (4-acetamidobenzoic acid) is a chemical compound with the molecular formula of C9H9NO3. It is the acetyl derivative of para-aminobenzoic acid (PABA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 45 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 129 | In Stock |
|
| 200MG | 181 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcedoben
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcedoben (4-acetamidobenzoic acid) is a chemical compound with the molecular formula of C9H9NO3. It is the acetyl derivative of para-aminobenzoic acid (PABA).
-
DescriptionAcedoben (4-acetamidobenzoic acid) is a chemical compound with the molecular formula of C9H9NO3. It is the acetyl derivative of para-aminobenzoic acid (PABA).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number556-08-1
-
Formula Weight179.17
-
Molecular FormulaC9H9NO3
-
Purity>98% (HPLC)
-
SolubilitySoluble in Water
-
SMILESCC(=O)NC1=CC=C(C=C1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Franklin MR, et al. Xenobiotica. 1971 Mar;1(2):121-30.
molnova catalog
related products
-
Saponarin
Saponarin shows in vitro and in vivo hepatoprotective and antioxidant activity against CCl4-induced liver damage.
-
HA15
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
-
SPR741
SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections.
